4DMedical develops advanced imaging software that converts medical imaging data into quantitative insights into lung function. The Company’s technology supports clinicians in assessing regional ventilation, perfusion and respiratory disease progression, with applications across pulmonology, radiology and cardiopulmonary care.
4DMedical’s portfolio includes XV Technology™, its foundational four-dimensional lung imaging platform, and CT:VQ™, a CT-based ventilation-perfusion solution that enables comprehensive cardiopulmonary analysis from standard CT scans.
Australian innovation with global commercial focus Developed from technology originally conceived at Monash University and now being commercialised in major healthcare markets.
Software-led, scalable model Designed to integrate with existing imaging workflows and infrastructure, supporting adoption without the need for major new hardware.
Regulatory-cleared product portfolio FDA-cleared technologies position 4DMedical to address clinical needs in respiratory and cardiopulmonary imaging.
Expanding market opportunity Targeting large global markets across respiratory diagnostics, CT imaging and advanced functional lung assessment.
Growing U.S. momentum Commercial partnerships and adoption across leading healthcare providers support 4DMedical’s pathway to scaled deployment and revenue growth.
